SHPH - דינמיקת הכנסות משנה לשנה ב-12 החודשים האחרונים shuttlepharma.com

Shuttle Pharmaceuticals (SHPH) total dependence on third-party laboratories and contractors contrasts with the development of breakthrough methods for enhancing radiation impact on brain tumors. This trailing twelve-month revenue chart helps correlate these factors, where 0.00 represents the current metric level. Currently, the business relies on the gradual depletion of existing cash reserves to fund critical scientific research.
פילוחי נתונים אנליטיים מרוכזים עבור Shuttle Pharmaceuticals Holdings (SHPH)

This indicator measures revenue dynamics over a rolling twelve-month period, allowing for an assessment of the actual business scaling speed and the risk of capital stagnation. By analyzing the Last Twelve Months (LTM) change in trading revenue, an investor can compare the sales growth rates of Shuttle Pharmaceuticals (SHPH) radiosensitizers with the expansion of oncology centers to determine the market potential of brain cancer therapy drugs.